$411 Million is the total value of Noked Israel Ltd's 50 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PPH | VANECK ETF TRUSTpharmaceutcl etf | $9,414,000 | -12.5% | 140,000 | 0.0% | 2.29% | -7.3% | |
IACC | ION ACQUISITION CORP 3 LTD | $4,343,000 | +1.2% | 440,000 | 0.0% | 1.06% | +7.2% | |
VERINT SYSTEMS INCnote 0.250% 4/1 added | $834,000 | -9.2% | 1,000,000 | 0.0% | 0.20% | -3.8% | ||
XTLB | XTL BIOPHARMACEUTICALS LTDsponsored adr ne | $221,000 | -26.8% | 198,888 | 0.0% | 0.05% | -21.7% | |
SVFD | SAVE FOODS INC | $143,000 | -43.9% | 75,455 | 0.0% | 0.04% | -40.7% | |
FTCH | FARFETCH LTDord sh cl a | $82,000 | -59.6% | 28,400 | 0.0% | 0.02% | -57.4% | |
TEKKW | TEKKORP DIGITAL ACQUISITN CO*w exp 10/26/202 | $2,000 | -83.3% | 75,000 | 0.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-12-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
XTL BIOPHARMACEUTICALS LTD | 20 | Q3 2023 | 0.5% |
MICROSOFT CORP | 19 | Q3 2023 | 17.6% |
SOLAREDGE TECHNOLOGIES INC | 15 | Q1 2023 | 47.3% |
APPLE INC | 15 | Q3 2023 | 11.8% |
AMAZON COM INC | 15 | Q3 2023 | 5.6% |
META PLATFORMS INC | 12 | Q3 2023 | 8.2% |
NOVA MEASURING INSTRUMENTS L | 11 | Q3 2023 | 7.0% |
ALIBABA GROUP HLDG LTD | 11 | Q2 2022 | 3.6% |
ALPHABET INC | 11 | Q3 2023 | 2.5% |
MONDAY COM LTD | 10 | Q3 2023 | 12.9% |
View Noked Israel Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR/A | 2022-12-27 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
View Noked Israel Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.